117 related articles for article (PubMed ID: 15010050)
21. Intravenous levetiracetam in children with seizures: a prospective safety study.
Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
[TBL] [Abstract][Full Text] [Related]
22. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
[TBL] [Abstract][Full Text] [Related]
23. Levetiracetam monotherapy for the treatment of infants with epilepsy.
Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
Seizure; 2018 Mar; 56():73-77. PubMed ID: 29453114
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M
Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
[TBL] [Abstract][Full Text] [Related]
25. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
26. Levetiracetam in children and adolescents with epilepsy and hemiplegic cerebral palsy.
Harbord MG
J Paediatr Child Health; 2011 May; 47(5):302-4. PubMed ID: 21244554
[TBL] [Abstract][Full Text] [Related]
27. Levetiracetam in pediatrics.
Vigevano F
J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of adjunctive levetiracetam in children younger than 4 years with refractory epilepsy].
Hu Y; Liao JX; Chen L; Huang TS; Li B
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr; 12(4):256-8. PubMed ID: 20416214
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial.
Lagae L; Buyse G; Ceulemans B
Seizure; 2005 Jan; 14(1):66-71. PubMed ID: 15642504
[TBL] [Abstract][Full Text] [Related]
30. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Perry S; Holt P; Benatar M
J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
[TBL] [Abstract][Full Text] [Related]
31. Intravenous levetiracetam in children with epilepsy.
Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
[TBL] [Abstract][Full Text] [Related]
32. Retrospective study of the use of levetiracetam in childhood seizure disorders.
Koukkari MW; Guarino EJ
J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
[TBL] [Abstract][Full Text] [Related]
33. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of levetiracetam: a review of three pivotal clinical trials.
Privitera M
Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
[TBL] [Abstract][Full Text] [Related]
35. Safety profile of levetiracetam.
Arroyo S; Crawford P
Epileptic Disord; 2003 May; 5 Suppl 1():S57-63. PubMed ID: 12915343
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam in childhood epilepsy.
Verrotti A; D'Adamo E; Parisi P; Chiarelli F; Curatolo P
Paediatr Drugs; 2010 Jun; 12(3):177-86. PubMed ID: 20486734
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
38. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.
Schiemann-Delgado J; Yang H; Loge Cde L; Stalvey TJ; Jones J; Legoff D; Mintz M
J Child Neurol; 2012 Jan; 27(1):80-9. PubMed ID: 21876066
[TBL] [Abstract][Full Text] [Related]
39. Rapid dosage titration of levetiracetam in children.
Vaisleib II; Neft RA
Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
[TBL] [Abstract][Full Text] [Related]
40. High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy.
Depositario-Cabacar DT; Peters JM; Pong AW; Roth J; Rotenberg A; Riviello JJ; Takeoka M
Epilepsia; 2010 Jul; 51(7):1319-22. PubMed ID: 20163437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
